Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53-Reference-Cited by-同舟云学术

Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53

Published:2021-01 Issue: Volume:79 Page:100780
ISSN:2212-4926
Container-title:Advances in Biological Regulation
language:en
Short-container-title:Advances in Biological Regulation

Author:

Abrams Stephen L.,Akula Shaw M.,Martelli Alberto M.,Cocco Lucio,Ratti Stefano,Libra Massimo,Candido Saverio,Montalto Giuseppe,Cervello Melchiorre,Gizak Agnieszka,Rakus Dariusz,Steelman Linda S.,McCubrey James A.^ORCID

Funder

East Carolina University

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology,Molecular Medicine

Reference126 articles.

1. Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells;Abrams;Oncotarget,2017

2. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals;Abrams;Adv. Biol. Regul.,2018

3. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells;Abrams;Adv. Biol. Regul.,2019

4. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer;Adamska;Adv. Biol. Regul.,2018

5. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells;Akula;Adv. Biol. Regul.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07

2. The Role of Nanomaterials in the Recent Development of Electrochemical Biosensors;Portugaliae Electrochimica Acta;2023

3. Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression;Cells;2022-07-09

4. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties;Aging;2022-04-27

5. Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53;Cells;2022-02-24